Skip to main content

Table 1 Baseline demographics, biochemical and hemodynamic characteristics of the 143 patients with psoriatic arthritis

From: The effect of marine n-3 polyunsaturated fatty acids on cardiac autonomic and hemodynamic function in patients with psoriatic arthritis: a randomised, double-blind, placebo-controlled trial

  

n-3 PUFA (N = 72)

Control (N = 71)

Total (N = 143)

Covariates

Age

   
 

Mean age

53.2 (11.4)

50.7 (11.5)

52.0 (11.5)

 

Sex

   
 

- Female

40 (55.6)

43 (60.6)

83 (58.0)

 

- Male

32 (44.4)

28 (39.4)

60 (42.0)

 

Smoking

   
 

- Non-smoker

36 (50.0)

41 (57.7)

77 (53.8)

 

- Former smoker

27 (37.5)

14 (19.7)

41 (28.7)

 

- Current smoker

9 (12.5)

16 (22.5)

25 (17.5)

 

Documented coronary heart disease

4 (5.6)

4 (5.6)

8 (5.6)

 

Hypertension

21 (29.2)

20 (28.2)

41 (28.7)

 

Hypercholesterolemia

18 (25.0)

11 (15.5)

29 (20.3)

 

NSAID use

40 (55.6)

32 (45.1)

72 (50.3)

Outcomes

Systolic BP, mmHg

138 (18)

134 (19)

136 (19)

 

Diastolic BP, mmHg

83 (11)

82 (12)

82 (12)

 

Hip and waste ratio

1.1 (0.1)

1.2 (0.1)

1.1 (0.1)

 

Body Mass Index

28.6 (5.7)

28.0 (5.0)

28.3 (5.4)

 

Disease Activity Score

2.5 (0.9)

2.7 (0.9)

2.6 (0.9)

 

CRP mg/l

4.6 (4.2)

6.1 (7.7)

5.3 (6.2)

 

PASI

2.2 (3.0)

2.3 (4.0)

2.3 (3.5)

 

Total cholesterol, mmol/l

5.0 (1.0)

4.8 (0.8)

4.9 (0.9)

  1. Data are given as mean (sd) or n (%) as appropriate
  2. N non-missing values, BP Blood pressure